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Introduction {#s1}
============

Necrotic enteritis (NE) is an acute clostridial disease of economic importance to the poultry industry [@pone.0114960-Hermans1]. NE is caused by *Clostridium perfringens*, a Gram-positive, rod-shaped, spore-forming, and oxygen-tolerant anaerobe [@pone.0114960-Lee1]. *C. perfringens* is a normal component of the chicken gut microbiota and the alterations in the host-pathogen relationship that regulate the development of NE remain to be determined [@pone.0114960-Songer1]. A variety of predisposing factors, however, are known to promote disease, including diets containing high levels of wheat, barley, or poorly digestible proteins and co-infection by the apicomplexan protozoa, *Eimeria*, the etiologic agent of avian coccidiosis [@pone.0114960-VanImmerseel1], [@pone.0114960-Timbermont1]. Because of the risk of transmission to humans through the food chain, *C. perfringens* also is important for public health [@pone.0114960-VanImmerseel1], [@pone.0114960-Olkowski1]. Traditionally, prophylactic in-feed antibiotics have proven effective for control of clostridial field infections in chickens. However, NE has recently emerged as a significant problem as a result of decreased antibiotic usage amid concerns over the appearance of antibiotic-resistant human pathogens [@pone.0114960-VanImmerseel1], [@pone.0114960-Lee2].

Only limited information exists on the role of genetic factors in controlling the susceptibility of chickens to NE. Since many common host immune responses are elicited following infection by viral, bacterial, or parasitic pathogens [@pone.0114960-Bumstead1], we hypothesized that two inbred chicken lines with dissimilar susceptibility to virus-induced diseases might provide insights into the genetic mechanisms regulating avian NE. White Leghorn USDA Avian Disease and Oncology Laboratory (ADOL) line 6 and line 7 chickens are 99% inbred and possess the major histocompatibility complex (MHC) *B^2^* genotype, but differ in their immunoglobulin G allotype (*G1^E^* and *G1^A^*, respectively). Both lines were originally selected based on their susceptibility to avian leukosis retroviruses (ALV) and Marek\'s diseases herpesviruses (MDV), with line 6 being the more susceptible to both viruses [@pone.0114960-Bacon1]. Although susceptibility to Marek\'s disease has not been associated with co-susceptibility *Eimeria* infection [@pone.0114960-Bumstead1], line 6 chickens do exhibit greater susceptibility to *E. maxima* infection compared with line 7 [@pone.0114960-Bumstead2]. However, no published studies have examined NE susceptibility in these two chicken lines. Therefore, the objectives of the current study were (1) to determine whether ADOL line 6 and line 7 exhibit different susceptibilities to experimental NE using a *C. perfringens*/*E. maxima* co-infection model and (2) to compare transcriptional profiles in co-infected *vs*. uninfected Ross chickens in order to identify candidate genes that might be differentially expressed in NE-afflicted line 6 *vs*. line 7 birds.

Materials and Methods {#s2}
=====================

Experimental animals {#s2a}
--------------------

Commercial Ross x Ross broilers were obtained from Longenecker\'s Hatchery (Elizabethtown, PA). ADOL line 6 and line 7 chickens were hatched at the USDA Avian Disease and Oncology Laboratory (East Lansing, MI). All chickens were housed in Petersime starter brooder units in an *Eimeria*-free facility for 14 days post-hatch and provided with feed and water *ad libitum*. Chickens were transferred to larger hanging cages with 2 birds/cage at a separate location where they were co-infected with *C. perfringens* and *E. maxima* and kept until the end of the experimental period.

Experimental NE disease model {#s2b}
-----------------------------

Chickens were infected with *E. maxima* strain 41A (1.0×10^4^ oocysts/bird) by oral gavage on day 14 post-hatch followed by infection with *C. perfringens* strain Del-1 (1.0×10^9^ colony forming units/bird) by oral gavage on day 18 [@pone.0114960-Jang1]. To facilitate development of NE, birds were fed an antibiotic-free, certified organic starter diet containing 17% crude protein between days 1--18 followed by a standard grower diet containing 24% crude protein between days 18--20. Uninfected control animals were housed in neighboring cages and given the same diet. Body weight gains (16 birds/group) were measured and fecal samples were collected between days 14--20 post-hatch (days 0--9 post-infection with *E. maxima*). Oocyst numbers were determined using a McMaster chamber (HK Inc., Tokyo, Japan) [@pone.0114960-Yoo1]. Gut lesion scores were determined at day 20 post-hatch (day 2 post-infection with *C. perfringens*) on a scale from 0 (none) to 4 (high) in a blinded fashion by three independent observers as described [@pone.0114960-Lee3], [@pone.0114960-Johnson1]. All protocols were approved by the USDA Beltsville Area Institutional Animal Care and Use Committee.

RNA extraction from intestinal intraepithelial lymphocytes (IELs) {#s2c}
-----------------------------------------------------------------

Total RNA was isolated from intestinal IELs of Ross chickens as described [@pone.0114960-Min1]. Briefly, the intestinal jejunum was removed at day 20 post-hatch, cut longitudinally, and washed three times with ice-cold Hank\'s balanced salt solution (HBSS). Harvested tissues were incubated in HBSS containing 0.5 mM EDTA and 5% FBS for 20 min at 37°C with constant swirling. Cells released into the supernatant were passed through nylon wool (Robbins Scientific, Sunnyvale, CA), and washed twice with HBSS containing 5% FBS. IELs were purified by Percoll density gradient centrifugation and washed three times with HBSS containing 5% FBS. Total RNA was isolated using Trizol (Invitrogen, Grand Island, NY).

Microarray hybridization {#s2d}
------------------------

RNA from 6 birds was pooled into 2 equal weight samples including RNA from 3 birds each. Each sample was labeled with cyanine 3 (Cy3)- or Cy5-CTP using the Two-Color Quick Amp Labeling Kit (Agilent Technologies, Santa Clara, CA) as described [@pone.0114960-Kim1]. Labeled RNAs from uninfected and *C. perfringens*/*E. maxima* co-infected chickens were hybridized with the Chicken Gene Expression Microarray (Agilent Technologies) containing 43,803 elements. Four hybridizations were conducted with alternation of Cy3- and Cy5-labeled RNAs to prevent data distortion from sample labeling [@pone.0114960-McShane1]. Microarray images were scanned and data extraction and analysis were performed using Feature Extraction software version 10.7.3.1 (Agilent Technologies).

Microarray data analysis {#s2e}
------------------------

GeneSpring GX10 software (Agilent Technologies) was used to qualify and normalize image analysis data and to determine the fold changes in gene expression. Average signal intensities were corrected for background signals and normalized by block locally-weighted regression scatterplot smoothing (LOWESS). Flag information, the feature quality data from the signals on microarray, was applied to the spots without blank or invalid values from each sample asymptotic t-test analysis with *P*\<0.05 was performed to analyze the significance of the differences between the uninfected and NE-afflicted groups. To generate signal ratios, signal channel values from NE-afflicted birds were divided by values from uninfected negative controls. All microarray information and data were deposited in the Gene Expression Omnibus database (series record number, GSE51154). Differentially expressed genes between NE-afflicted and uninfected control chickens were analyzed using Ingenuity Pathway Analysis (IPA) software (Ingenuity Systems, Redwood City, CA). Each identifier was mapped to its corresponding gene in IPA. These identified genes were superimposed onto the global molecular networks contained within IPA. IPA functional analysis was performed to identify the biological functions associated with the identified genes from the mapped datasets.

Quantitative (q)RT-PCR {#s2f}
----------------------

Equivalent amounts of the same intestinal IEL RNA used for microarray hybridization from uninfected or *C. perfringens*/*E. maxima* co-infected Ross chickens, and fresh IEL RNA from uninfected or co-infected ADOL line 6 and line 7 chickens, were reverse-transcribed using the AffinityScript Multiple Temperature cDNA Synthesis Kit (Agilent Technologies) as described [@pone.0114960-Collier1]. PCR amplification was performed using the oligonucleotide primers listed in [Table 1](#pone-0114960-t001){ref-type="table"} with the Mx3000P system and Brilliant SYBR Green qRT-PCR master mix (Agilent Technologies). Standard curves were generated using log~10~ diluted standard RNAs and the levels of individual transcripts were normalized to those of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) by the Q-gene program [@pone.0114960-Muller1]. The cycle threshold (C~t~) value of the target gene was normalized to GAPDH and calibrated to the relevant control value. Each analysis was performed in triplicate.

10.1371/journal.pone.0114960.t001

###### Oligonucleotide primers used for qRT-PCR.

![](pone.0114960.t001){#pone-0114960-t001-1}

  Gene Symbol                 Primer Sequence (5′→3′)                                        Entrez Gene Name                                    GenBank Accession No.
  ------------- --------- -------------------------------- ------------------------------------------------------------------------------------ -----------------------
  LCP1           Forward        GCCAGTAGACTGGAACAGAG                            Lymphocyte cytosolic protein 1 (L-plastin)                          NM_001008440.1
                 Reverse        TTCTCTCCACCACCAATATC                                                                                            
  MTTP           Forward        TTCCTATATGCCTGTGGATT                             Microsomal triglyceride transfer protein                           NM_001109784.1
                 Reverse        AGGTACATCCTCACGTTGTC                                                                                            
  CALB1          Forward        GCTTGGACTTAACACCTGAA                                       Calbindin 1, 28 kDa                                        NM_205513.1
                 Reverse        TCCTCAGAATCAATGAAACC                                                                                            
  CXCL14         Forward        CCAGTGCAGAAGGAGTAAAG                                Chemokine (C-X-C motif) ligand 14                                 NM_204712.2
                 Reverse        TTCCATACTCGGTACCACTT                                                                                            
  ANXA1          Forward        CAATGATGCAAGGGCCTTAT                                            Annexin A1                                            NM_206906.1
                 Reverse        CTTCATTGCCAGGTGGAGTT                                                                                            
  IL8            Forward        GGCTTGCTAGGGGAAATGA                                           Interleukin 8                                            AJ009800
                 Reverse      AGCTGACTCTGACTAGGAAACTGT                                                                                          
  APP            Forward   GGAAGCGATGATAAGGTGGTAGAAGAACAA                          Amyloid beta (A4) precursor protein                                 NM_204308
                 Reverse   CATCACCATCATCATCGTCATCATCATCAG                                                                                       
  ARHGEF6        Forward     ACTGCTGGGAAATGTGGAGGAAATC                     Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6                      NM_001006432
                 Reverse      ACGTCAGGTACAGGGAGCGGAACT                                                                                          
  BCL2           Forward       GATGTGCGTCGAGAGCGTCAA                                      B-cell CLL/lymphoma 2                                        NM_205339
                 Reverse        GTGCAGGTGCCGGTTCAGGT                                                                                            
  COL1A2         Forward    CTCAGCTTTGTGGATACGCGGATTTTG                                 Collagen, type I, alpha 2                                    NM_001079714
                 Reverse      GCCCTGCAGATGCCTCACTCACA                                                                                           
  CXCL14         Forward       GCCTTGCTTCTGCTGGTCATC                                Cchemokine (C-X-C motif) ligand 14                                 NM_204712
                 Reverse      ATCTTATTTTCGGCCCTTTCCTT                                                                                           
  GJA1           Forward   GTCTTCATGCTGGTAGTGTCTTTGGTGTCT                         Gap junction protein, alpha 1, 43 kDa                                NM_204586
                 Reverse     CTGTGGGAGTAGGGGTCGGTTTTTC                                                                                          
  HSP90B1        Forward      CTGGCTCTGGCATGCACGCTTCT                        Heat shock protein 90 kDa beta (Grp94), member 1                          NM_204289
                 Reverse   CTTCATCATCAGTTCGGGACCCTTCTCTAC                                                                                       
  NFKBIZ         Forward     CCAGGTCCTCCAGGCAATCCAAAAG      Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta       NM_001006254
                 Reverse     AGTGCAGGGCTGTCAAACCATCGTAG                                                                                         
  SERPINF1       Forward      CGGCAGCAGACAAGGGGAAGGATT                        Serpin peptidase inhibitor, clade F, member 1                          NM_001257289
                 Reverse     TGAAGTAAGCAGCCCCAGCAAGGAG                                                                                          
  SOCS3          Forward       GACACCAGCCTGCGCCTCAAGA                               Suppressor of cytokine signaling 3                                 NM_204600
                 Reverse      GCCCGTCACCGTGCTCCAGTAGA                                                                                           
  SOCS6          Forward    CAGATATCTTTGTGGACCAGGCAGTGAA                            Suppressor of cytokine signaling 6                               NM_001127312
                 Reverse   GGTAGCAAAGGTGAAAGTGGAGGGACATC                                                                                        
  TAB3           Forward       CACCGCAAAGACCTGGGACTG                       TGF-beta activated kinase 1/MAP3K7 binding protein 3                        XM_416787
                 Reverse     GTGGGTGCTGGTTTCGTTGAGATGGT                                                                                         
  TCF12          Forward    CTCGGGGAAACCTGGAACAACCTACTA                                  Transcription factor 12                                       NM_205375
                 Reverse    GGGGGCACCTTTCTTACTTTCTTTGTCT                                                                                        
  TNFRSF11B      Forward     CATCTCGGCCAACCAAGTCTCACCT                   Tumor necrosis factor receptor superfamily, member 11 b                     NM_001033641
                 Reverse   CGCTCGATATCTTCTTTTCCCACTTTCTTG                                                                                       
  TRAF3          Forward        CGTCTCGGCGCCACTTAGGA                                 TNF receptor-associated factor 3                                  XM_421378
                 Reverse       GGGCAGCCAGACGCAATGTTCA                                                                                           
  VEGFA          Forward       GGCCTAGAATGTGTCCCTGTGG                              Vascular endothelial growth factor A                              NM_001110355
                 Reverse      ATGTGCGCTATGTGCTGACTCTGA                                                                                          
  LITAF          Forward      TGTGTATGTGCAGCAACCCGTAGT                            Lipopolysaccharide-induced TNF factor                                AY765397
                 Reverse      GGCATTGCAATTTGGACAGAAGT                                                                                           
  GAPDH          Forward        TGCTGCCCAGAACATCATCC                             Glyceraldehyde-3-phosphate dehydrogenase                              NM_204305
                 Reverse        ACGGCAGGTCAGGTCAACAA                                                                                            

Statistical analyses {#s2g}
--------------------

Data from body weight gains, lesion scores, oocyst shedding, and mRNA expression levels were expressed as the mean ± SD values. Comparisons of the mean values were performed by ANOVA and the Student\'s t-test using SPSS software (SPSS 15.0 for Windows, Chicago, IL) and were considered significant at *P*\<0.05. IPA biological function analysis was performed using the Fisher\'s exact test to calculate the probability of each biological function assigned to that dataset and were considered significant at *P*\<0.05.

Results {#s3}
=======

Effects of experimental NE on body weight gain and lesion score {#s3a}
---------------------------------------------------------------

Co-infection of Ross chickens with *C. perfringens* and *E. maxima* reduced body weight gain between days 0--9 post-infection with *E. maxima* by 45% compared with uninfected birds (uninfected gain, 182±22 g; co-infected gain, 100±12 g) ([Fig. 1A](#pone-0114960-g001){ref-type="fig"}). Co-infected chickens also had higher gut lesion scores at day 2 post-infection with *C. perfringens* compared with uninfected chickens (uninfected score 0±0; co-infected score, 2.9±0.6) ([Fig. 1B](#pone-0114960-g001){ref-type="fig"}).

![Effect of *C. perfringens*/*E. maxima* co-infection of Ross chickens on body weight gains and intestinal lesion scores.\
(A) Chickens were uninfected (Control) or co-infected with *C. perfringens* and *E. maxima* (NE) and body weight gains were measured between days 0--9 post-infection with *E. maxima*. (B) Gut lesion scores were determined at day 2 post-infection with *C. perfringens* on a scale from 0 (none) to 4 (high) in a blinded fashion by three independent observers. Each bar represents the mean ± SD value (n = 8). \*, *P*\<0.05; \*\*\*, *P*\<0.001.](pone.0114960.g001){#pone-0114960-g001}

Effects of NE on global gene expression in intestinal IELs {#s3b}
----------------------------------------------------------

Microarray hybridization analysis identified 1,049 transcripts in intestinal IELs whose levels were significantly altered beyond a cutoff of\>2.0-fold at day 2 post-infection with *C. perfringens* in *C. perfringens*/*E. maxima* co-infected Ross chickens compared with uninfected controls. Of these, 601 transcript levels were increased and 448 were decreased. This dataset was mapped to the human, mouse, rat, and chicken genomes using Ingenuity Knowledge Base software, leading to the identification and annotation of 462 chicken genes. The most 20 most up-regulated and 20 most down-regulated transcripts in co-infected birds compared with uninfected controls are listed in [Table 2](#pone-0114960-t002){ref-type="table"}.

10.1371/journal.pone.0114960.t002

###### The 20 most up-regulated and 20 most down-regulated intestinal IEL transcript levels in *C. perfringens*/*E. maxima* co-infected Ross chickens compared with uninfected controls.
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  Symbol                                                           Entrez Gene Name                                              Fold Change        Location                 Type(s)
  -------------------- -------------------------------------------------------------------------------------------------------- ------------- --------------------- -------------------------
  **Up-regulated**                                                                                                                                                  
  MMP7                                                        Matrix metallopeptidase-7                                            45.476      Extracellular Space          Peptidase
  LYG2                                                            Lysozyme G-like 2                                                35.509      Extracellular Space           Enzyme
  VCAM1                                                   Vascular cell adhesion molecule 1                                        14.508        Plasma Membrane              Other
  ATP13A4                                                          ATPase type 13A4                                                12.263            Unknown               Transporter
  BATF3                                         Basic leucine zipper transcription factor, ATF-like 3                              11.368            Nucleus         Transcription Regulator
  TAC1                                                         Tachykinin, precursor 1                                              9.837      Extracellular Space            Other
  C3                                                            Complement component 3                                               9.8       Extracellular Space          Peptidase
  SOCS1                                                   Suppressor of cytokine signaling 1                                        9.571           Cytoplasm                 Other
  LAG3                                                       Lymphocyte-activation gene 3                                           9.217        Plasma Membrane     Transmembrane Receptor
  GLDC                                                 Glycine dehydrogenase (decarboxylating)                                      8.991           Cytoplasm                Enzyme
  IL21R                                                        Interleukin 21 receptor                                              8.101        Plasma Membrane     Transmembrane Receptor
  RRM2                                                       Ribonucleotide reductase M2                                            7.797            Nucleus                 Enzyme
  SAMHD1                                                      SAM domain and HD domain 1                                            7.729            Nucleus                 Enzyme
  MIS12                                     MIS12, MIND kinetochore complex component, homolog (S. pombe)                           7.474            Nucleus                  Other
  CSF2RA                          Colony stimulating factor 2 receptor, alpha, low-affinity (granulocyte-macrophage)                7.444        Plasma Membrane     Transmembrane Receptor
  IRG1                                                    Immunoresponsive 1 homolog (mouse)                                        7.171            Unknown                  Other
  MDFI                                                          MyoD family inhibitor                                               7.161           Cytoplasm                 Other
  TRAIP                                                        TRAF interacting protein                                             7.09            Cytoplasm                 Other
  SFTPA1                                                        Surfactant protein A1                                               7.003      Extracellular Space         Transporter
  SMC2                                                 Structural maintenance of chromosomes 2                                      6.872            Nucleus               Transporter
  **Down-regulated**                                                                                                                                                
  C13orf15                                               Chromosome 13 open reading frame 15                                      −104.868          Cytoplasm                 Other
  AGXT2L1                                            Alanine-glyoxylate aminotransferase 2-like 1                                  −70.677           Unknown                 Enzyme
  CMBL                                            Carboxymethylenebutenolidase homolog (Pseudomonas)                               −28.026           Unknown                 Enzyme
  HES6                                                Hairy and enhancer of split 6 (Drosophila)                                   −25.238           Nucleus         Transcription Regulator
  RBPMS2                                             RNA binding protein with multiple splicing 2                                  −22.282           Unknown                  Other
  S100B                                                     S100 calcium binding protein B                                         −17.322          Cytoplasm                 Other
  SERPINF1              Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1     −17.216     Extracellular Space            Other
  SERPINB2                                    Serpin peptidase inhibitor, clade B (ovalbumin), member 2                            −16.241     Extracellular Space            Other
  BBOX1                         Butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1              −15.873          Cytoplasm                Enzyme
  RHAG                                                        Rh-associated glycoprotein                                           −13.518       Plasma Membrane            Peptidase
  CXCL14                                                  Chemokine (C-X-C motif) ligand 14                                        −13.029     Extracellular Space          Cytokine
  MYL10                                                   Myosin, light chain 10, regulatory                                       −12.77           Cytoplasm                 Other
  TMEM199                                                     Transmembrane protein 199                                            −12.112           Unknown                  Other
  ANXA1                                                               Annexin A1                                                   −11.609       Plasma Membrane              Other
  NRG4                                                               Neuregulin 4                                                  −11.399     Extracellular Space        Growth Factor
  ALDH1A1                                             Aldehyde dehydrogenase 1 family, member A1                                   −10.85           Cytoplasm                Enzyme
  RNF152                                                       Ring finger protein 152                                             −10.558          Cytoplasm                Enzyme
  COL1A2                                                      Collagen, type I, alpha 2                                            −10.196     Extracellular Space            Other
  SYNM                                                  Synemin, intermediate filament protein                                     −9.059           Cytoplasm                 Other
  CALB1                                                          Calbindin 1, 28 kDa                                               −8.966           Cytoplasm                 Other

Effects of NE on biological function, pathway, and network analysis of differentially regulated IELs transcripts {#s3c}
----------------------------------------------------------------------------------------------------------------

Five significantly altered biological functions were identified from the differently altered genes in intestinal IELs from *C. perfringens*/*E. maxima* co-infected Ross chickens compared with uninfected controls ([Table 3](#pone-0114960-t003){ref-type="table"}). The *P* value associated with a particular function in this analysis is a statistical measure of the likelihood that genes from the dataset under investigation participate in that function. All of the 5 identified biological functions were related to the immune response, particularly the quantity and movement of leukocytes. The most significant function annotated was "immune response" including a category of "inflammatory response" with 83 genes, followed by "cell movement of leukocytes" including the categories of "cellular movement," "hematological system development and function," and "immune cell trafficking" with 49 genes.

10.1371/journal.pone.0114960.t003

###### The biological functions significantly associated with the differentially expressed transcripts in *C. perfringens*/*E. maxima* co-infected Ross chickens compared with uninfected controls.
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  Functions Annotation                                    Category                      *P* Value   No. of Genes
  ------------------------------------ ----------------------------------------------- ----------- --------------
  Immune response                                   Inflammatory Response               5.93E-12         83
  Cell movement of leukocytes                         Cellular Movement                 1.36E-09         49
                                        Hematological System Development and Function              
                                                   Immune Cell Trafficking                         
  Quantity of leukocytes                Hematological System Development and Function   1.96E-09         45
                                                      Tissue Morphology                            
  Cell movement of blood cells                        Cellular Movement                 2.21E-09         53
  Quantity of mononuclear leukocytes    Hematological System Development and Function   2.52E-09         38
                                                      Tissue Morphology                            

Canonical pathway analysis of the differentially expressed genes in co-infected *vs*. uninfected chickens identified 11 pathways ([Table 4](#pone-0114960-t004){ref-type="table"}). The most significant of these were "leukocyte extravasation signaling," "relaxin signaling," and "LPS/IL-1 mediated inhibition of RXR function", which were associated with 14, 11, and 13 genes, respectively ([Table 5](#pone-0114960-t005){ref-type="table"}).

10.1371/journal.pone.0114960.t004

###### The IPA pathways significantly associated with the differentially expressed transcripts in *C. perfringens*/*E. maxima* co-infected Ross chickens compared with uninfected controls.
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  Ingenuity Canonical Pathway                              *P* Value   Ratio[\*](#nt101){ref-type="table-fn"}
  ------------------------------------------------------- ----------- ----------------------------------------
  Leukocyte Extravasation Signaling                        1.58E-03                   7.00E-02
  Relaxin Signaling                                        1.82E-03                   6.96E-02
  LPS/IL-1 Mediated Inhibition of RXR Function             2.29E-03                   5.83E-02
  Pyruvate Metabolism                                      2.82E-03                   5.19E-02
  Neuroprotective Role of THOP1 in Alzheimer\'s Disease    2.88E-03                   9.26E-02
  HIF1α Signaling                                          2.95E-03                   8.33E-02
  ATM Signaling                                            7.08E-03                   1.11E-01
  HMGB1 Signaling                                          7.41E-03                   8.00E-02
  Tight Junction Signaling                                 8.32E-03                   6.10E-02
  ILK Signaling                                            9.33E-03                   6.22E-02
  Hepatic Fibrosis/Hepatic Stellate Cell Activation        9.77E-03                   6.80E-02

^\*^The ratio of the number of genes from the dataset mapped to the indicated pathway divided by the total number of genes within that particular pathway.

10.1371/journal.pone.0114960.t005

###### Genes included in the three canonical pathways most significantly associated with the differentially expressed transcripts in *C. perfringens*/*E. maxima* co-infected Ross chickens compared with uninfected controls.
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  Pathway                                         Gene Symbol                                      Entrez Gene Name                                       Fold Change        Location                 Type(s)
  ---------------------------------------------- ------------- ----------------------------------------------------------------------------------------- ------------- --------------------- -------------------------
  Leukocyte Extravasation Signaling                  CD99                                            CD99 molecule                                          −4.524        Plasma Membrane              Other
                                                     ACTC1                                  Actin, alpha, cardiac muscle 1                                  −3.201           Cytoplasm                Enzyme
                                                     CTTN                                              Cortactin                                            −2.679        Plasma Membrane              Other
                                                     MAPK9                                Mitogen-activated protein kinase 9                                −2.154           Cytoplasm                Kinase
                                                   ARHGAP12                                Rho GTPase activating protein 12                                  −2.1            Cytoplasm                 Other
                                                     CLDN3                                             Claudin 3                                            −2.098        Plasma Membrane     Transmembrane Receptor
                                                      FER                                Fer (fps/fes related) tyrosine kinase                               2.279           Cytoplasm                Kinase
                                                    PIK3R5                          Phosphoinositide-3-kinase, regulatory subunit 5                          2.584           Cytoplasm                Kinase
                                                     MMP9        Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)       3.071      Extracellular Space          Peptidase
                                                     NCF2                                    Neutrophil cytosolic factor 2                                   3.464           Cytoplasm                Enzyme
                                                    PIK3CD                      Phosphoinositide-3-kinase, catalytic, delta polypeptide                      3.775           Cytoplasm                Kinase
                                                     RAC2       Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)      3.919           Cytoplasm                Enzyme
                                                     VCAM1                                 Vascular cell adhesion molecule 1                                14.508        Plasma Membrane              Other
                                                     MMP7                           Matrix metallopeptidase 7 (matrilysin, uterine)                         45.476      Extracellular Space          Peptidase
  Relaxin Signaling                                  MPPE1                                     Metallophosphoesterase 1                                      2.005           Cytoplasm                Enzyme
                                                     PDE3B                               Phosphodiesterase 3B, cGMP-inhibited                                2.18            Cytoplasm                Enzyme
                                                    PIK3CD                      Phosphoinositide-3-kinase, catalytic, delta polypeptide                      3.775           Cytoplasm                Kinase
                                                    PIK3R5                          Phosphoinositide-3-kinase, regulatory subunit 5                          2.584           Cytoplasm                Kinase
                                                     MMP9        Matrix metallopeptidase 9 (gelatinase B, 92kDa gelatinase, 92kDa type IV collagenase)       3.071      Extracellular Space          Peptidase
                                                     VEGFA                               Vascular endothelial growth factor A                               −2.245      Extracellular Space        Growth Factor
                                                     CREB1                             cAMP responsive element binding protein 1                             2.05             Nucleus         Transcription Regulator
                                                     ADCY5                                        Adenylate cyclase 5                                        −2.53        Plasma Membrane             Enzyme
                                                     ADCY9                                        Adenylate cyclase 9                                       −3.136        Plasma Membrane             Enzyme
                                                     GNA11                Guanine nucleotide binding protein (G protein), alpha 11 (Gq class)               −2.271        Plasma Membrane             Enzyme
                                                     GNG13                     Guanine nucleotide binding protein (G protein), gamma 13                     −3.434        Plasma Membrane             Enzyme
  LPS/IL-1 Mediated Inhibition of RXR Function      ACSBG2                           Acyl-CoA synthetase bubblegum family member 2                           2.046           Cytoplasm                Enzyme
                                                     ACSL5                          Acyl-CoA synthetase long-chain family member 5                           4.067           Cytoplasm                Enzyme
                                                    ALDH1A1                           Aldehyde dehydrogenase 1 family, member A1                            −10.85           Cytoplasm                Enzyme
                                                    CYP3A4                       Cytochrome P450, family 3, subfamily A, polypeptide 4                       2.265           Cytoplasm                Enzyme
                                                     FABP5                        Fatty acid binding protein 5 (psoriasis-associated)                       −2.642           Cytoplasm              Transporter
                                                     GSTT1                                 Glutathione S-transferase theta 1                                −2.622           Cytoplasm                Enzyme
                                                    HMGCS2                     3-hydroxy-3-methylglutaryl-CoA synthase 2 (mitochondrial)                    −6.489           Cytoplasm                Enzyme
                                                     MAPK9                                Mitogen-activated protein kinase 9                                −2.154           Cytoplasm                Kinase
                                                     SMOX                                          Spermine oxidase                                         −2.372           Cytoplasm                Enzyme
                                                    HS6ST1                              Heparan sulfate 6-O-sulfotransferase 1                               2.632        Plasma Membrane             Enzyme
                                                    SLC27A4                   Solute carrier family 27 (fatty acid transporter), member 4                    2.839        Plasma Membrane           Transporter
                                                   TNFRSF11B                    Tumor necrosis factor receptor superfamily, member 11b                       −4.19        Plasma Membrane     Transmembrane Receptor
                                                   TNFRSF1B                      Tumor necrosis factor receptor superfamily, member 1B                       4.62         Plasma Membrane     Transmembrane Receptor

Twenty-five networks related to the differentially expressed genes in co-infected *vs*. uninfected chickens were identified by IPA network analysis ([S1 Table](#pone.0114960.s001){ref-type="supplementary-material"}). Two of these networks were related to the immune response, including the most significantly associated network containing 25 focused genes and associated with the biological functions "cellular function and maintenance", "inflammatory response", and "cell-to-cell signaling and interaction" ([Fig. 2A](#pone-0114960-g002){ref-type="fig"}). The seventh most significantly associated network also was related to the immune response and contained 21 focused genes associated with the biological functions "cell death," "inflammatory response," and "organismal injury and abnormalities" ([Fig. 2B](#pone-0114960-g002){ref-type="fig"}).

![The first (A) and seventh (B) networks of genes most significantly associated with the differentially expressed transcripts in *C. perfringens*/*E. maxima* co-infected Ross chickens compared with uninfected controls.\
Up- and down-regulated genes are illustrated by red and green, respectively. The color intensity directly correlates with the difference in the expression level of the corresponding gene compared between line 6 and line 7 chickens.](pone.0114960.g002){#pone-0114960-g002}

Validation of microarray analysis by qRT-PCR {#s3d}
--------------------------------------------

The transcript expression patterns observed by microarray analysis between *C. perfringens*/*E. maxima* co-infected Ross chickens and uninfected controls were validated by qRT-PCR for 15 immune-related mRNAs. The levels of all transcripts were consistently increased or decreased by each method of quantification ([Fig. 3](#pone-0114960-g003){ref-type="fig"}). The some cases, differences in the magnitude of the changes observed by the two techniques might be related to differences in the normalization methods used and/or the different fluorescent dyes used [@pone.0114960-Lee4].

![Comparison of the fold changes in the expression levels of 15 immune-related gene transcripts in intestinal IELs of *C. perfringens*/*E. maxima* co-infected Ross chickens (NE) compared with uninfected controls (Control).\
Transcript levels were analyzed by microarray hybridization and qRT-PCR in both groups. Each bar represents the mean ± SD value of the fold change in the transcript level (n = 3). ANXA1, Annexin A1; APP, Amyloid precursor protein; ARHGEF6, Rho guanine nucleotide exchange factor 6; CALB1, Calbindin 1; COL1A2, Collagen, type 1, alpha 2; CXCL14, Chemokine (C-X-C motif) ligand 14; GJA1, Gap junction alpha 1; HSP90B1, Heat shock protein 90kDa beta 1; VEGFA, Vascular endothelial growth factor A; ALCAM, Activated leukocyte cell adhesion molecule; MTTP, Microsomal triglyceride transfer protein; LCP1, Lymphocyte cytosolic protein 1; TNFSF11B, Tumor necrosis factor superfamily 11; SERPINE1, Serpin peptidase inhibitor, clade F1.](pone.0114960.g003){#pone-0114960-g003}

Body weight gain, oocyst shedding, and immune-related gene expression during experimental NE in ADOL line 6 and line 7 chickens {#s3e}
-------------------------------------------------------------------------------------------------------------------------------

Line 6 chickens had reduced body weight gains between days 0--9 post-infection with *E. maxima* (line 6 gain, 0.5±7.0 g; line 7 gain, 16±5.0 g) ([Fig. 4A](#pone-0114960-g004){ref-type="fig"}). Body weight gains between these same time points were equal in the two lines in uninfected birds. Co-infected line 6 chickens had greater fecal oocyst shedding between days 0--9 post-infection with *E. maxima* compared with line 7 chickens (line 6 oocyts, 3.9±1.5×10^6^; line 7 oocysts, 2.5±1.4×10^6^) ([Fig. 4B](#pone-0114960-g004){ref-type="fig"}). These results suggest that line 6 chickens have increased susceptibility for the development of experimental NE compared with line 7 chickens. To characterize the pattern of immune-related gene expression that might be related to this observed difference in disease susceptibility, the levels of transcripts for 21 selected genes were analyzed by qRT-PCR in uninfected and *C. perfringens*/*E. maxima* co-infected line 6 and line 7 chickens. Of these, 15 transcripts were expressed at greater levels in co-infected line 6 chickens compared with line 7 birds, 5 were equal in the two lines, and 1 was decreased in co-infected line 6 *vs*. line 7 chickens ([Table 6](#pone-0114960-t006){ref-type="table"}).

![Effect of *C. perfringens*/*E. maxima* co-infection of ADOL line 6 and line 7 chickens on body weight gains and oocyst shedding.\
(A) Chickens were uninfected (Control) or co-infected with *C. perfringens* and *E. maxima* (NE) and body weight gains were measured between days 0--9 post-infection with *E. maxima*. Bars with different letters are significantly different according to the Duncan\'s multiple range test (*P*\<0.05). (B) Fecal oocyst shedding was measured between days 0--9 post-infection with *E. maxima* in *C. perfringens*/*E. maxima* co-infected chickens. Each bar represents the mean ± SD value (n = 8). \*, *P*\<0.05.](pone.0114960.g004){#pone-0114960-g004}

10.1371/journal.pone.0114960.t006

###### Immune-related intestinal IEL transcript levels in uninfected and in *C. perfringens*/*E. maxima* co-infected ADOL line 6 and line 7 chickens.

![](pone.0114960.t006){#pone-0114960-t006-6}

  Gene         Treatment        ADOL Line 6           ADOL Line 7
  ----------- ------------ --------------------- ---------------------
  ANXA1        Uninfected   3.6E-03±2.5E-04^c^    6.5E-03±4.5E-04^b^
                   NE       1.0E-02±7.4E-05^a^    1.6E-03±9.4E-05b^c^
  ARHGEF6      Uninfected   1.9E-03±7.8E-06^c^    2.4E-03±6.9E-05^b^
                   NE       3.3E-03±1.0E-04^a^    2.6E-03±9.9E-05^b^
  LITAF        Uninfected   2.0E+00±3.6E-01^b^    6.7E-01±2.6E-02^c^
                   NE       4.8E+00±2.7E-01^a^    8.3E-01±3.7E-02^c^
  SOCS3        Uninfected   1.3E-08±1.9E-09^b^    4.0E-07±1.6E-08^b^
                   NE       3.0E-06±1.1E-07^a^    9.2E-07±3.5E-08^b^
  BCL2         Uninfected   2.7E-04±1.6E-05^b^    5.1E-04±2.1E-05^a^
                   NE       2.2E-04±7.4E-06^b^    1.3E-04±9.3E-06^c^
  GJA1         Uninfected   5.5E-05±3.5E-06^a^    1.8E-05±3.4E-06^b^
                   NE       1.2E-05±3.7E-07^b^    1.6E-05±9.7E-07^b^
  IL8          Uninfected   1.5E+00±1.0E-01^a^    7.2E-01±6.3E-02^b^
                   NE       5.7E-01±1.1E-02^b^    4.4E-01±6.2E-02^b^
  SOCS6        Uninfected   7.5E-04±3.9E-05^a^    2.6E-04±6.7E-06^b^
                   NE       2.6E-04±9.7E-06^b^    2.3E-04±8.1E-06^b^
  HSP90B1      Uninfected   1.2E-02±2.1E-04^b^    1.3E-02±3.0E-04^b^
                   NE       1.6E-02±3.8E-04^a^    3.9E-03±8.1E-05^c^
  VEGFA        Uninfected   2.6E-02±3.6E-04^b^    2.8E-02±6.0E-04^b^
                   NE       4.1E-02±4.0E-04^a^    1.6E-02±3.1E-04^c^
  MTTP         Uninfected   6.1E-06±1.7E-07^bc^   3.1E-06±9.4E-08^c^
                   NE       2.9E-05±6.2E-07^a^    9.4E-06±7.2E-07^b^
  SERPINF1     Uninfected   3.8E-04±2.2E-05^b^    1.5E-03±2.7E-05^a^
                   NE       7.7E-05±2.1E-06^c^    1.3E-04±8.0E-06^c^
  CALB1        Uninfected   2.6E+00±7.5E-02^a^    7.3E-01±3.5E-02^b^
                   NE       3.7E-03±6.0E-05^c^    5.7E-02±9.2E-03^c^
  LCP1         Uninfected   3.4E-06±2.8E-07^c^    2.8E-06±3.5E-07^c^
                   NE       3.2E-05±3.8E-07^a^    4.6E-05±3.9E-06^b^
  TNFRSF11B    Uninfected   1.9E-07±9.5E-09^a^    1.3E-07±2.3E-08^b^
                   NE       1.0E-07±9.2E-09^b^    3.3E-08±5.4E-09^c^
  COL1A2       Uninfected   2.9E-04±2.8E-05^ab^   3.7E-04±2.6E-05^a^
                   NE       1.2E-04±7.3E-06^c^    2.4E-04±2.7E-05^b^
  TCF12        Uninfected   2.3E-04±1.4E-05^a^    1.1E-04±1.2E-05^b^
                   NE       1.6E-04±2.7E-05^b^    6.1E-05±3.5E-06^c^
  APP          Uninfected   1.9E-02±1.2E-04^a^    1.2E-02±3.0E-04^b^
                   NE       1.1E-02±3.0E-04^b^    5.1E-03±1.4E-04^c^
  CXCL14       Uninfected   9.6E-04±5.4E-05^a^    2.6E-04±1.5E-05^b^
                   NE       3.1E-04±7.7E-05^b^    5.2E-05±4.8E-06^c^
  NFKBIZ       Uninfected   2.4E-03±9.9E-05^b^    6.0E-03±1.6E-04^a^
                   NE       1.8E-03±4.6E-05^c^    1.3E-03±1.5E-05^d^
  TAB3         Uninfected   1.9E-03±1.2E-05^a^    1.2E-03±1.2E-05^b^
                   NE       4.4E-04±1.6E-05^c^    2.4E-04±1.1E-05^d^
  TRAF3        Uninfected   1.9E-03±3.4E-05^a^    6.8E-04±5.1E-06^b^
                   NE       6.0E-04±1.9E-05^b^    2.5E-04±9.7E-06^c^

Each value represents the mean ± SD (n = 3). Within each gene group, values with different superscripts are significantly different according to the Duncan\'s multiple range test (*P*\<0.05).

Discussion {#s4}
==========

This study was conducted to investigate the host response to avian NE, and the role of host genetics in this response, using an experimental model of *C. perfringens*/*E. maxima* co-infection. Microarray hybridization identified 1,049 transcripts whose levels were altered in intestinal IELs of co-infected Ross chickens compared with uninfected controls, the majority of which (57.3%) were increased. From these differentially expressed genes, 5 biological functions, all related to host immunity, and 11 pathways were identified. ADOL line 6 chickens were more susceptible to NE compared with the MHC-identical line 7, as revealed by decreased body weight gain and increased *E. maxima* oocyst shedding. Of note, body weight gains of the experimentally inbred ADOL chickens are lower compared with those of Ross broilers which have been specifically bred for rapid, high efficiency growth rate. Of 21 pro- and anti-inflammatory genes examined, 15 were increased in line 6 *vs*. line 7 chickens. It is interesting to note that most of immune-related transcripts examined (71%) were increased in the more disease susceptible line 6 chickens.

Identification of antibiotic-free disease control strategies against NE has been hindered due, in large part, to the difficulty of experimentally reproducing the disease by *C. perfringens* infection alone [@pone.0114960-Collier1], [@pone.0114960-Park1]. Nevertheless, several prior studies have profiled chicken transcriptome changes following infection by *C. perfringens* alone [@pone.0114960-Sarson1], [@pone.0114960-Zhou1]. Functional genomics using the *C. perfringens*/*E. maxima* co-infection method offers one possibility to investigate the host response to experimental disease, and to the best of our knowledge, this study is the first report of such an approach. We chose to analyze transcriptome alterations using intestinal IELs because they are the primary immune effector cells of the gut-associated lymphoid tissues which recognize and destroy pathogens that breach the intestinal epithelial barrier [@pone.0114960-Neutra1]. Chicken intestinal IELs are composed of two phenotypically and functionally distinct subpopulations, natural killer cells and T-lymphocytes [@pone.0114960-Gobel1], and both cell types are major effectors against *C. perfringens* and *Eimeria* spp. [@pone.0114960-Lillehoj1].

In addition to infection of the chicken gut, *C. perfringens* infection also can be manifested as gangrenous dermatitis, a necrotizing skin disease accompanied by severe cellulitis of the subcutaneous tissues [@pone.0114960-Kim2]. In a previous study, we characterized gene expression profiles in chickens with gangrenous dermatitis and identified "inflammatory response" as the most significantly affected biological functions associated with this disease [@pone.0114960-Kim2]. Therefore, it was not unexpected to find in the current study that the differentially regulated genes in intestinal IELs from chickens with experimental NE also were associated with biological functions and networks related to "inflammatory response" and "immune response". Interestingly, all of the remaining significantly annotated biological functions in *C. perfringens*/*E. maxima* co-infected Ross birds were related to movement or quantity of leukocytes. Further, the most reliable canonical pathway identified was "leukocytes extravasation signaling". Leukocyte extravasation from the vasculature into infected interstitial tissues constitutes a key component of the host inflammatory response. Inflammatory cytokines and proteases, particularly matrix metalloproteinases (MMPs), are released by extravasating cells to modify the extracellular matrix [@pone.0114960-Feng1]--[@pone.0114960-Wilson1]. Our results now establish that both matrix MMP-7 and MMP-9 were up-regulated in intestinal IELs of co-infected birds compared with uninfected controls. Collectively, the results suggest that the movement and/or quantity of leukocytes regulate host resistance to experimental avian NE.

ADOL lines 6 and 7 are homozygous for the MHC *B^2^* haplotype, but differ in MDV and ALV resistance [@pone.0114960-Liu1], [@pone.0114960-Yu1]. Line 6 chickens are susceptible to both MDV and ALV infection, whereas line 7 chickens are relatively resistant to infection by these viruses. The current study now extends the differential response of these two lines to experimental NE, where line 6 chickens showed greater susceptibility to *C. perfringens*/*E. maxima* co-infection compared with line 7 birds. Of the 21 immune-related transcripts analyzed in line 6 and line 7 birds, 15 were increased in the more disease susceptible line 6 chickens. The levels of 9 of these up-regulated transcripts also were examined in Ross chickens, where 8 were increased following *C. perfringens*/*E. maxima* co-infection compared with uninfected controls (ANXA1, HSP90B1, VEGFA, MTTP, TNFSF11B, TCF12, APP, and CXCL14). In humans, annexin A1 (ANXA1) regulates tumor necrosis factor-α (TNF-α)-induced cell proliferative and inflammatory responses [@pone.0114960-Jia1]. In other human studies, annexin A1 protein acted as a positive regulator of MMP-9 expression, as well as metastatic invasion of breast cancer cells, through activation of NF-κB signaling [@pone.0114960-Kang1]. The expression of LPS-induced TNF-α factor (LITAF), a transcription factor that regulates inflammation through transcriptional activation of TNF-α [@pone.0114960-Ji1], [@pone.0114960-Zhou2], also was increased in *C. perfringens*/*E. maxima* co-infected line 6 chickens compared with line 7 birds. Counteracting these proinflammatory effects, suppressors of cytokine signaling (SOCS) proteins act in an anti-inflammatory manner by providing a negative feedback loop to attenuate cytokine signaling. Mouse TNF-α, and by inference chicken LITAF, were responsible for the maintenance of SOCS3 expression *in vitro* and TNF-α deficiency in murine macrophages accelerated the degradation of SOCS3 protein [@pone.0114960-Dagvadorj1]. In the current study, LITAF and SOCS3 were increased in co-infected ADOL line 6 chickens compared with line 7 birds. Therefore, the susceptibility to experimental avian NE might be determined, at least in part, by interactions among ANXA1, LITAF, SOCS, and/or other proteins encoded by genes that are differentially regulated in line 6 *vs*. line 7 chickens during experimental NE. Future studies are needed to provide additional insights into the host-pathogen interactions in avian NE that might facilitate the development of effective control strategies against field infections by clostridial bacteria.
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Significant networks from the differentially expressed transcripts (\>2.0 fold changes, P\<0.05) following NE infection compared with uninfected controls.
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